Dr. Allen Frances, a professor emeritus at Duke University and the Chair of the DSM IV Task Force, has written that informed consent is a vital component to medical treatment and should be required, in writing, for all use of medication. Dr. Frances finds that informed consent is particularly incomplete in the case of off-label use of medications (when the FDA has not approved use of the drug to treat the condition for which it is being prescribed). He calls off-label use “the wild west of medicine.” For people with dementia, who are often prescribed off-label antipsychotic and other drugs despite their known serious health risks, the wild west comes with a modern day Boot Hill (cemetery). There is currently no law that explicitly requires prescribers to tell their patients when a drug prescribed is for an off-label use. That’s just crazy.